Patents by Inventor Helle Krogh Ottow

Helle Krogh Ottow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TNF antagonists
    Patent number: 7820622
    Abstract: TNF binding polypeptides based on human tetranectin C-type lectin like domains (CTLD) with improved binding characteristics and improved efficacy. The polypeptides comprise a TNF binding domain having the amino acid sequence KRWS-RYF (SEQ ID NO:1). Also provided are methods of preparing the polypeptides of the invention. The polypeptides may be used for the preparation of pharmaceutical compositions, and for treatment of a subject having a pathology mediated by TNF, such as treatment of rheumatoid arthritis.
    Type: Grant
    Filed: November 21, 2005
    Date of Patent: October 26, 2010
    Assignee: Anaphore, Inc.
    Inventors: Helle Krogh Ottow, Mette Munch, Thor Las Holtet, Mikkel Holmen Andersen, Josephus Dirk Nieland
  • TNF ANTAGONISTS
    Publication number: 20090155843
    Abstract: TNF binding polypeptides based on human tetranectin C-type lectin like domains (CTLD) with improved binding characteristics and improved efficacy. The polypeptides comprise a TNF binding domain having the amino acid sequence KRWS-RYF (SEQ ID NO:1). Also provided are methods of preparing the polypeptides of the invention. The polypeptides may be used for the preparation of pharmaceutical compositions, and for treatment of a subject having a pathology mediated by TNF, such as treatment of rheumatoid arthritis.
    Type: Application
    Filed: November 21, 2005
    Publication date: June 18, 2009
    Applicant: Anaphore, Inc.
    Inventors: Helle Krogh Ottow, Mette Munch, Thor Las Holtet, Mikkel Holmen Andersen, Josephus Dirk Nieland